Golden Ally Lifetech Group, Inc.
AQPW · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $31,107 | $19,990 | $17,036 | $15,954 |
| - Cash | $191 | $582 | $1,426 | $2,915 |
| + Debt | $84 | $101 | $117 | $133 |
| Enterprise Value | $31,000 | $19,508 | $15,726 | $13,172 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$17 | -$17 | -$17 | -$6 |
| % Margin | – | – | – | – |
| EBITDA | -$2,410 | -$1,069 | -$1,401 | -$1,580 |
| % Margin | – | – | – | – |
| Net Income | -$2,428 | -$1,088 | -$1,418 | -$1,585 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.033 | -0.015 | -0.017 | -0.02 |
| % Growth | -123.1% | 12% | 16.5% | – |
| Operating Cash Flow | -$665 | -$845 | -$1,494 | -$1,416 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$665 | -$845 | -$1,494 | -$1,416 |